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Abstract We previously reported that the metabotropic gluta-
mate receptor1K (mGluR1K) has a sensitivity to extracellular
polyvalent cations such as Ca2+ and Gd3+ as well as glutamate.
Gd3+ binding site was recently identi¢ed by crystal structure
analysis at the interface of two subunits including Glu238, but
it remains unknown whether this site is functionally involved in
the activation of mGluR1K by Gd3+ or not. We analyzed the
ligand sensitivity of the Glu238Gln mutant, and observed that
the sensitivity to extracellular Gd3+ was completely lost, while
the sensitivity to glutamate and Ca2+ was not a¡ected. We also
observed that the presence of Gd3+ increased the sensitivity of
mGluR1K to glutamate, and that this e¡ect was again lost by
Glu238Gln mutation. These results suggest that the binding of
Gd3+ or a related endogenous substance to this site, alone or in
cooperation with glutamate binding at a distant site, leads
mGluR1K to activation.
+ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The G protein-coupled metabotropic glutamate receptor1K
(mGluR1K) [1,2] is one of eight mGluR subtypes
(mGluR1VmGluR8) that have been cloned and classi¢ed
into three categories. Group I mGluRs (mGluR1 and
mGluR5) couple to phospholipase C to activate protein ki-
nase C and promote the release of Ca2þ from intracellular
stores. There is also substantial evidence that group I mGluRs
play critical roles in some forms of synaptic plasticity, includ-
ing long-term potentiation and long-term depression [3^7].
We previously reported that mGluR1K is activated not only
by glutamate but also by extracellular Ca2þ ([Ca2þ]o) and
Gd3þ ([Gd3þ]o) in Xenopus oocytes [8], and in transiently
transfected Human embryonic kidney cells (HEK293) [9],
although we could not observe responses to [Gd3þ]o in a sta-
bly transfected Chinese Hamster Ovary (CHO) cell line to
which we applied a high dose (more than 1 mM) of [Gd3þ]o
[10,11]. Based on the di¡erence in the sensitivity to [Ca2þ]o
between mGluR1 and mGluR2, we identi¢ed S166 in the
extracellular domain as a site critical for the sensitivity to
[Ca2þ]o [8].
The crystal structure of the extracellular domain of
mGluR1K was solved by X-ray di¡raction analysis, and two
glutamate binding pockets were identi¢ed in the dimer struc-
ture [12] (Fig. 1, blue). It was also shown that mGluR1K has
two conformational states, open^open/Resting and closed^
open/Active, and the binding of glutamate shifts the equilib-
rium between the two states to the closed^open/Active state
[12]. Here ‘open’ and ‘closed’ mean the relative position of the
upper and lower lobes of each clam-like subunit. In Fig. 1, the
subunit on the left is in the closed state, while that on the
right is in the open state [12]. The discrimination of ‘Resting’
and ‘Active’ is based on the manner of the contact between
the dimer interface at the upper lobe [12].
Binding of Ca2þ to mGluR1K was not clearly observed in a
crystal at S166 (Fig. 1, red) adjacent to the glutamate binding
site (Fig. 1, blue) [12]. A high-a⁄nity binding site for Mg2þ
and possibly for Ca2þ was identi¢ed at N118 by crystal struc-
ture analysis [12]. However, being located too far from S166,
this site was speculated not to be part of the reported site
critical for the sensitivity to [Ca2þ]o. These results show the
possibility that the agonistic e¡ect of [Ca2þ]o, with a Kd value
larger than 2 mM, is not due to a high-a⁄nity binding to
S166, but due to a sort of loose interaction here.
On the other hand, the binding of [Gd3þ]o to mGluR1K was
clearly observed in a crystal grown in the presence of 0.5 mM
Gd3þ [13]. It located at the dimer interface where negatively
charged amino acids including E238 are clustered (Fig. 1,
green, E238 in cyan), and the site was distant from the bind-
ing pocket for glutamate (Fig. 1, blue). In the presence of
both glutamate and Gd3þ, mGluR1K was shown to take the
third conformational state, closed^closed/Active [13], a state
di¡erent from that caused by glutamate alone. In spite of
these structural observations, it remains unknown whether
the [Gd3þ]o binding site actually plays a functional role in
the activation of mGluR1K by [Gd3þ]o.
In this study we aimed to functionally identify the Gd3þ
binding site (E238) and compared the sensitivities of
mGluR1K wild type (w.t.) and E238GlnQ as well as S166D
mutants to glutamate, [Ca2þ]o and [Gd3þ]o. We also analyzed
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the e¡ect of the constant presence of [Gd3þ]o on the sensitivity
of mGluR1K to glutamate.
2. Materials and methods
2.1. Molecular biology
Point mutants were made using mutated primers and a Quick-
Change site-directed mutagenesis kit (Stratagene), and were subcloned
into pCXN2 [14] expression vector. The FLAG epitope
(DYKDDDDK) was inserted into the N-terminus of mGluR1K be-
tween amino acids 57 and 58 by the two-step PCR (polymerase chain
reaction)-based mutagenesis method as described previously [15], and
then subcloned into pCXN2. The sequence of the constructs was
con¢rmed by DNA sequencing (ABI Prism 310).
HEK293 were transfected with the appropriate expression plasmids
using LipofectAMINE PLUS (Invitrogen) according to the manufac-
turer’s instructions. Also cotransfected was pDsRed-N1 (10% of the
total DNA) (Clonetech) encoding a £uorescent reporter protein,
DsRed. The cells were used between 24 and 48 h after transfection.
2.2. Measurement of intracellular Ca2+ ([Ca2+]i)
[Ca2þ]i was measured essentially as described previously [11] with
some modi¢cations. Culture medium was mixed with 5 WM Fura-2
AM (Molecular Probe) and 0.01% Cremophor EL (Sigma) by vortex-
ing and by ultrasonic vibration for 15 s, after which transiently trans-
fected cells were incubated in this mixture for 20^40 min at 37‡C
under 5% CO2. The cells were then rinsed and incubated at room
temperature for up to 1.5 h in basal solution (140 mM NaCl, 4 mM
KOH, 10 mM HEPES (pH 7.4)) supplemented with 1 mM MgCl2,
1.5 mM CaCl2 and 10 mM glucose. In some experiments, the cover-
slip was rinsed with basal solution supplemented with 0.3 mM Mg2þ
just before the experiments. This rinse was done only for a few min-
utes to avoid depletion of [Ca2þ]i stores, which would hamper re-
sponses. The coverslip was then placed in a recording chamber ¢lled
with 200 Wl of basal solution supplemented with 0.3 mM Mg2þ and
0 mM (Figs. 3B,C and 4) or 1.5 mM [Ca2þ]o (Fig. 3A). To achieve
abrupt changes in ligand concentration, 400 Wl of 150% concentrated
stock solution was applied by pipet. [Ca2þ]i was monitored as a func-
tion of the ratio of the 510 nm Fura-2 emission excited by illumina-
tion at 340 and 380 nm applied using a Lambda DG-4 light source
and ¢lter exchanger (Sutter, Novato, CA, USA). Fura-2 £uorescence
was recorded using a MicroMAX 512BFT cooled CCD camera (Ro-
per Scienti¢c, Tucson, AZ, USA) and Meta£uor imaging software
(Universal Imaging, Downingtown, PA, USA).
2.3. Immunocytochemistry
To analyze surface expression of mGluR1K, live cells expressing
FLAG-tagged mGluR1K were ¢rst blocked in 5% skim milk in phos-
phate-bu¡ered saline (PBS) without detergent on ice for 1 h and then
incubated with an anti-FLAG monoclonal antibody (clone M2, Sig-
ma; 4 Wg ml31) on ice for 1 h. They were then ¢xed in 4% parafor-
maldehyde in PBS on ice for 10 min, rinsed with PBS three times, and
blocked in 5% skim milk in PBS without detergent at 37‡C for 1 h.
They were incubated with Alexa488-conjugated anti-mouse IgG
(1:500; Molecular Probes) in 5% skim milk without detergent at
37‡C for 1 h. Labeled cells were rinsed and mounted in PermaFluor
(Shandon, Pittsburgh, PA, USA). Fluorescent images were captured
with a BX-50 microscope (Olympus) equipped with an AxioCam
CCD camera unit (Zeiss) and were analyzed with Scion Image soft-
ware (Scion Corp., Frederick, MD, USA). To compare the expression
level of mGluR1K quantitatively, we always carried out staining of
three samples in parallel, and used a constant exposure time of 10 s in
all cases.
Fig. 1. Structure of the ligand binding domain of mGluR1K. A graphic presentation was created by Rasmol software based on the data
#1EWK in the Protein Data Bank [12]. It represents a structure in a closed^open/Active state [12]. The two subunits show a dimeric structure.
Amino acid residues reported to be involved in the glutamate binding (Y74, S164, S165, S186, T188, D208, Y236, E292, G293, D318, R323,
K409) [12] are marked in blue, and those in [Gd3þ]o binding (D191, D242, K260) [13] are marked in green, except for E238, which is marked
in cyan. S166 we identi¢ed to have an in£uence to sensitivity to [Ca2þ]o [8] was marked in red. E238 and S166 which were mutated in this
study are marked by arrows.
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2.4. Statistical analysis
Data are presented as meansVS.E. Means were compared using
unpaired t-tests unless speci¢ed otherwise. Values of P6 0.05 were
considered signi¢cant.
3. Results
3.1. Cell surface expression of mGluR1K
The di¡erence in responses between cells transfected with
mGluR1K w.t. and those with mutants could be due to the
di¡erence in either the expression level or the ligand sensitiv-
ity. We ¢rst analyzed the surface distribution of FLAG-
tagged mGluR1K w.t., S166D and E238Q by performing pri-
mary antibody reaction at 4‡C without permeabilizing the
cells (Fig. 2A^C). In cells expressing mGluR1K w.t., the cell
surface receptors appeared as bright punctate spots of £uo-
rescence suggestive of receptor clustering at the plasma mem-
brane (Fig. 2A). S166D and E238Q mutants showed highly
similar distributions (Fig. 2B,C). These surface expression lev-
els did not show statistically signi¢cant di¡erence (Fig. 2D,
107.3V 6.1 A.U. (n=23, w.t.), 93.6 V 3.8 A.U. (n=75, S166D),
94.7V 5.3 A.U. (n=44, E238Q)). Thus, the changes of the
ligand-evoked responses of the mutants observed in the fol-
lowing experiments were believed not to be due to the changes
of the surface expression level but to the ligand sensing func-
tion.
3.2. Comparison of the ligand sensitivities of mGluR1K w.t.,
S166D and E238Q
The responses of mGluR1K were monitored optically as
increases in [Ca2þ]i in HEK293 transfectants loaded with
the £uorescent Ca2þ indicator Fura-2. Examples of the re-
sponses of mGluR1K w.t., S166D and E238Q to 10 WM glu-
tamate in the presence of 1.5 mM [Ca2þ]o are shown (Fig.
3A), and their dose^response relationships were compared
(Fig. 3B). The sensitivity to glutamate was not at all changed
by E238Q mutation, while it was reduced by S166D mutation
as reported previously [9,11]. The e¡ect of S166D mutation to
glutamate sensitivity was less clear in the absence of [Ca2þ]o
[8,11].
An abrupt increase in [Ca2þ]o from 0 to 10 mM also evoked
transient increase in [Ca2þ]i in HEK293 cells expressing
mGluR1K w.t. (Fig. 3C). These responses reached their peaks
with a time course which was similar to that of the responses
to 100 WM glutamate but signi¢cantly faster than that of the
[Ca2þ]i transients in mock transfected cells probably due to
in£ux of Ca2þ, as we reported previously [9]. Thus, [Ca2þ]o-
evoked changes in [Ca2þ]i were not initiated by the Ca2þ
in£ux but by metabotropic reactions. We assumed [Ca2þ]i
transients that reached their peak within 50 s after changing
[Ca2þ]o to be [Ca2þ]o-evoked responses mediated by
mGluR1K. S166D mutant did not show clear evoked-re-
sponses to 10 mM [Ca2þ]o (Fig. 3C), suggesting much reduced
sensitivity, while E238Q mutant showed clear responses (Fig.
3C). The sensitivity of E238Q to [Ca2þ]o was at a similar level
to w.t., as shown in the plots of the dose^response relation-
ship (Fig. 3D).
Recordings of the responses to 0.1 mM [Gd3þ]o are shown
in Fig. 3E. The dose^response relationship of w.t. for [Gd3þ]o
was di¡erent from those for glutamate and [Ca2þ]o, in that it
Fig. 2. E¡ects of S166D or E238Q mutation on the cell surface expression of mGluR1K. Fluorescence micrographs of HEK293 cells expressing
FLAG-tagged mGluR1K w.t. (A), S166D (B), or E238Q (C). The scale bars indicate 10 Wm. D: Quantitative comparison of the surface expres-
sion levels of mGluR1K w.t., S166D and E238Q. The average £uorescence intensities in 2U10 Wm regions of cell surface were measured. Bars
depict meansVS.E.
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was bell-shaped, i.e. the amplitude of responses decreased at
both low and high concentrations (Fig. 3F). As the rate of
decay of the Gd3þ response was accelerated at a high concen-
tration of the cation [9], we believe that this abrupt loss of
e¡ect at high concentration is due to an inactivating (or de-
sensitizing) process taking place prior to activation. S166D
mutant showed a bell-shaped dose^response relationship sim-
ilar to that of w.t., but the sensitivity was completely lost in
E238Q. As D191, D242 and K260 (Fig. 1 green) are also
located at the [Gd3þ]o binding site [13], we examined the sen-
sitivity of [Gd3þ]o of D191N, D242N and K260Q mutants.
D191N and K260Q mutants showed a similar sensitivity to
w.t., while that of D242N was slightly decreased (data not
shown). These results demonstrate the primary signi¢cance
of E238 together with D242 in the activation of mGluR1K
by [Gd3þ]o.
3.3. E¡ect of the constant presence of [Gd 3+]o on the response
of mGluR1K to glutamate
In the previous section, it was shown [Gd3þ]o alone has an
agonistic action and it is lost in E238Q mutant. If [Gd3þ]o acts
as an agonist by changing the equilibrium of the two confor-
mations by binding to negatively charged amino acid(s) at the
interface of two subunits, [Gd3þ]o could potentiate the e¡ect
of glutamate on the activation which binds at a distant site
(Fig. 1, blue). We, therefore, investigated the e¡ect of [Gd3þ]o
on glutamate-evoked responses. In Fig. 4A, responses to 100
WM glutamate in the presence of various [Gd3þ]o was ana-
lyzed. [Gd3þ]o was basally included in the bath in this experi-
ment, and glutamate was applied without changing [Gd3þ]o
after the responses triggered by [Gd3þ]o subsided. The re-
sponses of mGluR1K w.t. to glutamate were signi¢cantly in-
creased by low concentrations (e.g. 10 WM) of [Gd3þ]o, and
this e¡ect was not observed in E238Q mutant. In the presence
of high concentrations of [Gd3þ]o, glutamate responses disap-
peared completely. It is possible that the e¡ect of high con-
centrations of [Gd3þ]o to eliminate responses to [Gd3þ]o de-
scribed above also suppressed responses to glutamate.
However, this suppressive e¡ect of [Gd3þ]o was not a¡ected
by E238Q mutation (Fig. 4A), suggesting that the structural
background for it is di¡erent from E238.
Next, we compared the glutamate dose^response relation-
ship in the presence and absence of 0.01 mM [Gd3þ]o (Fig.
4B). It was clear that the presence of 0.01 mM [Gd3þ]o sig-
Fig. 3. Ligand-evoked [Ca2þ]i transients mediated by mGluR1K w.t., S166D and E238Q. A: Glutamate-evoked [Ca2þ]i transients. The traces
show the transient increases in [Ca2þ]i evoked by 10 WM glutamate monitored as the changes in the ratio of 510 nm Fura-2 emission excited
by illumination at 340 and 380 nm; [Ca2þ]o = 1.5 mM. Cells expressed mGluR1K w.t. (left), S166D (middle) or E238Q (right). B: Plots of glu-
tamate dose^response relationship for w.t. (¢lled circles), S166D (¢lled triangles) and E238Q (open squares). C,D: Same as A and B. Record-
ings of the response to abrupt increase in [Ca2þ]o from 0 to 10 mM (C) and [Ca2þ]o dose^response relationship (D) are shown. E,F: Same as
A and B. Recordings of the responses to 0.1 mM [Gd3þ]o (E) and Gd3þ dose^response relationship (F) are shown. [Ca2þ]o = 0 mM.
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ni¢cantly increased the sensitivity of mGluR1K to glutamate,
while this e¡ect was not observed in E238Q.
4. Discussion
We previously identi¢ed S166 of mGluR1K as a site critical
for [Ca2þ]o sensing function [8], and a region including E238
was recently reported to be a [Gd3þ]o binding site by crystal
structure analysis [13]. A [Gd3þ]o binding site di¡erent from
that for glutamate is also reported on ionotropic kainate re-
ceptors [16]. In the present study we compared sensitivities of
mGluR1K w.t., S166D and E238Q to glutamate, [Ca2þ]o and
[Gd3þ]o, and obtained the results as follows. (1) S166D muta-
tion abolished responses to [Ca2þ]o (Fig. 3D) and decreased
sensitivity to glutamate (Fig. 3B). (2) E238Q mutation abol-
ished responses to [Gd3þ]o (Fig. 3F) without changing sensi-
tivities to glutamate (Fig. 3B) and [Ca2þ]o (Fig. 3D). (3)
[Gd3þ]o potentiated glutamate-evoked responses (Fig. 4),
and this potentiating e¡ect was lost completely by E238Q
mutation (Fig. 4). (4) A high dose of [Gd3þ]o could not evoke
responses and also suppressed responses to glutamate com-
pletely. This suppressive e¡ect on glutamate-evoked responses
was not a¡ected by E238Q mutation.
What is the structural background for the potentiation ef-
fect of [Gd3þ]o on glutamate response, and its suppressive
e¡ect at high dose? We discuss three points in the following
by combining our data with those of the crystal structure
analysis [12,13]. (1) Potentiation of glutamate response by
[Gd 3+]o. The [Gd3þ]o binding site identi¢ed by crystal struc-
ture analysis is located at the dimer interface where negatively
charged amino acids including E238 and D242 are clustered
[13]. We speculate that binding of [Gd3þ]o neutralizes negative
charges at the dimer interface, facilitating the approach of the
interface at the lower lobes, and make the receptor enter a
potentiated ‘Active’ state di¡erent from that caused by gluta-
mate alone. The state could be closed^closed/Active proposed
by Tsuchiya et al. in the presence of both glutamate and
[Gd3þ]o [13]. (2) Activation by [Gd 3+]o alone. We demon-
strated that [Gd3þ]o alone can activate mGluR1K, and E238
plays a critical role in this step. The results suggest a possi-
bility that mGluR1K can take the conformation of open^
open/Active. [Gd3þ]o might cause the approach of the dimer
interface of the lower lobes, even if both of the two subunits
are in the open state. Kunishima et al. predicted the existence
of the open^open/Active state by model building [12]. (3)
Suppressive e¡ect of [Gd 3+]o. [Gd3þ]o also leads mGluR1K
to another unidenti¢ed inactivated (or desensitized) state,
which was apparently observed by applying a high concentra-
tion of [Gd3þ]o. There could be two possible explanations.
(3a) mGluR1K might enter a kind of inactivated state, when
¢rmly stabilized at the closed^closed/(potentiated) Active state
by a high concentration of [Gd3þ]o and glutamate. Transitions
between the Resting and the Active state might be necessary
for the functional signal transduction. (3b) Tsuchiya et al.
identi¢ed two additional [Gd3þ]o binding sites on the external
surface of mGluR1K [13]. Although they discussed that they
may not play critical roles for activation of mGluR1K, it is
possible that the binding of [Gd3þ]o at these sites could cause
suppression of the receptor function. Of these two possibil-
ities, the latter might be more likely when the result is taken
into account that E238Q mutation did not a¡ect the suppres-
sive e¡ect.
There is one point with a discrepancy in the results. It is the
di¡erence between the e¡ective range of the agonist e¡ect of
[Gd3þ]o alone (Fig. 3F) and that of the potentiating e¡ect of
[Gd3þ]o to glutamate responses in mGluR1K w.t. (Fig. 4A).
This di¡erence could be explained by the di¡erence in the
experimental conditions. In Fig. 3F, we abruptly applied
Gd3þ to the bath and plotted the peak amplitude of
[Gd3þ]o-evoked responses. In Fig. 4A, Gd3þ at various con-
centrations was basally included in the bath, and we plotted
the peak amplitude of glutamate-evoked responses. Thus, it is
not surprising that the e¡ective range of [Gd3þ]o di¡ers in
these two cases.
It goes without saying that Gd3þ does not exist physiolog-
ically in cerebro spinal £uid (CSF) at a concentration su⁄-
cient to activate mGluR1K. What then is the physiological
role of the [Gd3þ]o binding site? One extreme and negative
possibility is that the [Gd3þ]o binding site does not have any
physiological signi¢cance at all, i.e. all positive results, the
presence of the binding site in the crystal and the recorded
responses, were observed just by chance. The second possibil-
ity is that the [Gd3þ]o binding of mGluR1K has a role to
Fig. 4. E¡ect of the presence of [Gd3þ]o on the responses to gluta-
mate. A: Amplitudes of the responses to 100 WM glutamate in the
presence of various concentrations of [Gd3þ]o. ** at 1 WM and 10
WM indicates signi¢cant di¡erence (P6 0.01). B: Comparison of the
glutamate dose^response relationship of mGluR1K w.t. (circles) and
E238Q (squares) in the absence (open symbols) and presence (¢lled
symbols) of 0.01 mM [Gd3þ]o.
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detect toxic exogenous substances, i.e. heavy metals. The third
possibility is that there is an endogenous extracellular sub-
stance X which mimics the action of [Gd3þ]o. The substance
X may regulate the sensitivity of mGluR1K to glutamate by a
similar potentiating e¡ect to that of [Gd3þ]o.
An attractive and challenging question is what the sub-
stance X is. It would be positively charged, and small enough
to ¢t in the dimer interface. One obvious candidate may be
[Ca2þ]o, as discussed by Tsuchiya et al. [13]. However, we
showed that the agonistic e¡ect of [Ca2þ]o alone was not
a¡ected by E238Q mutation (Fig. 3B), suggesting that E238
is not involved in the agonistic action of [Ca2þ]o alone. A
possibility still remains that a potentiating e¡ect of [Ca2þ]o
on the glutamate-evoked response [11] is mediated by the
binding of [Ca2þ]o to E238Q. To examine this possibility,
we compared the dose^response relationships of glutamate
in the presence and absence of [Ca2þ]o. An enhancing e¡ect
by [Ca2þ]o on the sensitivity to glutamate was observed in
mGluR1K w.t. and similarly in the E238Q mutant (data not
shown). These results suggest that the enhancing e¡ect of
[Ca2þ]o on the glutamate-evoked response is not mediated
by E238, either. As the second candidate for the substance
X, we speculated polyamines such as spermine, spermidine
and putrescine. These are long thin molecules with four, three
or two positive charges, respectively. Although polyamines are
more abundant in the cytoplasm, they is also present in CSF
[17]. For these reasons, the shape, polyvalent positive charges
of the molecules and existence in CSF, we decided to examine
if polyamines have an agonistic e¡ect and/or a potentiating
e¡ect on glutamate responses. However, none of them acti-
vated mGluR1K when applied alone, nor showed clear e¡ects
to enhance glutamate sensitivity (data not shown). Therefore,
a physiological endogenous substance which interacts with
mGluR1K at E238 still remains to be identi¢ed.
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